Chronic myeloid leukemia with extremely high platelet count requires purchasing Plavix and imatinib mesylate capsules.

Chronic granulocytic leukemia generally refers to chronic myeloid leukemia, a type of myeloproliferative tumor often accompanied by abnormally elevated platelet levels. Plavix generally refers to clopidogrel hydrogen sulfate tablets, commonly used to prevent and treat circulatory disorders in the heart, brain, and other arteries caused by a highly active platelet state. Imatinib mesylate capsules are commonly used in the treatment of chronic myeloid leukemia; they can inhibit the proliferation of leukemia cells, thereby controlling the progression of the disease.

Clopidogrel hydrogen sulfate tablets are not a conventional treatment for chronic myeloid leukemia and should not be used on one's own initiative to treat extremely high platelet levels. Imatinib mesylate capsules are among the drugs used for treating chronic myeloid leukemia. During treatment, medication must be strictly taken as directed by the physician, and regular follow-up tests including blood counts, bone marrow examinations, and genetic testing should be conducted.

Patients should ensure adequate rest, avoid fatigue, prevent infections, maintain a positive mindset, and actively cooperate with treatment during the course of therapy.